Company Overview and News


Add XRAY
to your dashboard

Headline News

Align Technology’s Growth Prospects amid Increasing Competition

2018-01-02 marketrealist
Align Technology (ALGN) is growing at an accelerated pace with its market-leading Invisalign clear aligners. The company generates revenues through two segments: Clear Aligner and Scanner & Services. (34-0)

Patterson Companies' (PDCO) Dental Segment Shows Weakness

2017-12-28 zacks
Patterson Companies, Inc. (PDCO - Free Report) has had an unimpressive run on the bourses in the last three months, trading below the industry. Further, lackluster performance in the dental segment along with a downbeat guidance is a concern. The stock has a Zacks Rank #5 (Strong Sell). (7-0)

Free Post Earnings Research Report: DENTSPLY SIRONA’s Revenue Grew 5.8%; Adjusted EPS Surged 6.1%

2017-12-15 accesswire
LONDON, UK / ACCESSWIRE / December 15, 2017 / Active-Investors free earnings report on DENTSPLY SIRONA Inc. (NASDAQ: XRAY) has freshly been issued to its members, and you can also sign up to view this report at www.active-investors.com/registration-sg/?symbol=XRAY. The Company posted its financial results on November 02, 2017, for the third quarter fiscal 2017. The Company's revenue and adjusted EPS surpassed analysts' expectations. (1-0)

U.S. says Dentsply Sirona to pay $1.2 mln settlement over exports to Iran

2017-12-06 reuters
WASHINGTON (Reuters) - Dentsply Sirona Inc has agreed to pay $1.2 million to settle apparent Iranian sanctions violations by two of its subsidiaries, the U.S. Treasury Department’s Office of Foreign Assets Control said on Wednesday. (0-1)

Amazon to disrupt the dentist next? Dental supplier stocks drop on new threat

2017-12-06 cnbc
Shares of dental supply distibutors sank Wednesday after Morgan Stanley issued a stark warning to investors: "Amazon is here." (17-0)

Align Teams Up with Exocad to Expand in Digital Scanning

2017-11-28 zacks
Align Technologies (ALGN - Free Report) has continued to develop its iTero scanner line and is fast expanding its footprint in the growing field of digital scanning. In sync with this strategy, the company has announced plans to advance its iTero Element intraoral scanner through the strategic partnership with Exocad GmbH. (31-0)

Tracking Al Gore's Generation Investment Management Portfolio - Q3 2017 Update

2017-11-25 seekingalpha
The top three positions are Cerner, Acuity Brands, and Microsoft, and they add up to ~23% of the entire portfolio. (392-1)

Tracking Allan Mecham's Arlington Value Capital Portfolio - Q3 2017 Update

2017-11-24 seekingalpha
Arlington Value Capital’s 13F portfolio value increased from $874M to $1B. The number of positions increased from 23 to 24. (226-2)

DENTSPLY SIRONA Strong on Deal Renewals, Forex Woes Stay

2017-11-21 zacks
On Nov 20, we issued an updated research report on DENTSPLY SIRONA Inc. (XRAY - Free Report) — a global leader in the design, development, manufacture and marketing of dental consumables and dental laboratory products. (50-0)

Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q3 2017 Update

2017-11-21 seekingalpha
Halvorsen's 13F portfolio value increased from $14.85B to $15.44B. The number of positions increased from 53 to 59. (1331-7)

Align Technology-Glidewell Dental Deal to Boost iTero Uptake

2017-11-20 zacks
Align Technology, Inc. (ALGN - Free Report) recently signed an agreement with Glidewell Dental to distribute the iTero Element intraoral scanning system with the latest glidewell.io In-Office Solution in North America. (29-0)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets 2 FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-13)

Your Daily Pharma Scoop: Portola Ahead Of Catalysts, AstraZeneca Gets Two FDA Approvals, GW Pharmaceuticals' Price Target Lowered

2017-11-15 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (1487-2)

Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q3 2017 Update

2017-11-14 seekingalpha
Ruane, Cunniff, & Goldfarb’s 13F portfolio value increased ~6%, from $10.81B to $11.42B. The number of positions decreased from 70 to 69. (386-3)

Earnings Review and Free Research Report: C.R. Bard’s Revenue Grew 5%; Adjusted EPS Increased 14.3%

2017-11-13 accesswire
LONDON, UK / ACCESSWIRE / November 13, 2017 / Pro-Trader Daily has just published a free post-earnings coverage on C.R. Bard, Inc. (NYSE: BCR), which can be viewed by registering at http://protraderdaily.com/optin/?symbol=BCR, following the Company's posting of its financial results on October 25, 2017, for the third quarter fiscal 2017. The medical device manufacturer's revenue and earnings beat estimates. (52-0)

CUSIP: 24906P109